Annegret Buske

1.4k total citations
18 papers, 908 citations indexed

About

Annegret Buske is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Annegret Buske has authored 18 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Rheumatology. Recurrent topics in Annegret Buske's work include Neurofibromatosis and Schwannoma Cases (16 papers), Sarcoma Diagnosis and Treatment (9 papers) and Soft tissue tumor case studies (7 papers). Annegret Buske is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (16 papers), Sarcoma Diagnosis and Treatment (9 papers) and Soft tissue tumor case studies (7 papers). Annegret Buske collaborates with scholars based in Germany, United States and Portugal. Annegret Buske's co-authors include Sigrid Tinschert, Peter Nürnberg, Andreas Gewies, Hartmut Peters, Dieter Kaufmann, Dieter E. Jenne, Raimund Fahsold, Gundula Thiel, Sven Hoffmeyer and Christoph Gille and has published in prestigious journals such as Journal of the American Society of Nephrology, The American Journal of Human Genetics and Genomics.

In The Last Decade

Annegret Buske

18 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annegret Buske Germany 13 566 327 236 227 215 18 908
Raimund Fahsold Germany 14 397 0.7× 344 1.1× 128 0.5× 159 0.7× 130 0.6× 27 777
Antonia Gaona Spain 13 474 0.8× 165 0.5× 203 0.9× 94 0.4× 354 1.6× 16 808
Francis S. Collins United States 11 627 1.1× 543 1.7× 96 0.4× 182 0.8× 327 1.5× 14 1.4k
Claudia Mischung Germany 6 205 0.4× 234 0.7× 133 0.6× 119 0.5× 82 0.4× 6 565
Peter Dirks Canada 15 424 0.7× 295 0.9× 84 0.4× 38 0.2× 114 0.5× 31 935
Heli Ylä‐Outinen Finland 13 372 0.7× 121 0.4× 137 0.6× 46 0.2× 165 0.8× 22 660
Allan E. Rubenstein United States 17 658 1.2× 250 0.8× 181 0.8× 46 0.2× 148 0.7× 34 1.0k
Donna C. Rich United States 7 241 0.4× 260 0.8× 75 0.3× 176 0.8× 88 0.4× 8 580
Anna Maria Buccoliero Italy 17 197 0.3× 271 0.8× 67 0.3× 73 0.3× 141 0.7× 86 860
SM Huson United Kingdom 7 487 0.9× 125 0.4× 168 0.7× 44 0.2× 132 0.6× 14 600

Countries citing papers authored by Annegret Buske

Since Specialization
Citations

This map shows the geographic impact of Annegret Buske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annegret Buske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annegret Buske more than expected).

Fields of papers citing papers by Annegret Buske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annegret Buske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annegret Buske. The network helps show where Annegret Buske may publish in the future.

Co-authorship network of co-authors of Annegret Buske

This figure shows the co-authorship network connecting the top 25 collaborators of Annegret Buske. A scholar is included among the top collaborators of Annegret Buske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annegret Buske. Annegret Buske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zirn, Birgit, Luitgard Graul‐Neumann, M. Suckfüll, et al.. (2013). Spectrum of novel mutations found in Waardenburg syndrome types 1 and 2: implications for molecular genetic diagnostics. BMJ Open. 3(3). e001917–e001917. 38 indexed citations
2.
Bergmann, Carsten, Nadina Ortiz Brüchle, Valeska Frank, et al.. (2011). Mutations in Multiple PKD Genes May Explain Early and Severe Polycystic Kidney Disease. Journal of the American Society of Nephrology. 22(11). 2047–2056. 161 indexed citations
3.
Peters, Hartmut, Sandra Währisch, Thomas Harder, et al.. (2009). Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients. European Journal of Human Genetics. 18(1). 81–87. 20 indexed citations
4.
Oexle, Konrad, Denise Horn, Annegret Buske, et al.. (2005). Childhood overgrowth in patients with common NF1 microdeletions. European Journal of Human Genetics. 13(7). 883–888. 30 indexed citations
5.
Jenne, Dieter E., Sigrid Tinschert, Peter Nürnberg, et al.. (2000). A Common Set of at Least 11 Functional Genes Is Lost in the Majority of NF1 Patients with Gross Deletions. Genomics. 66(1). 93–97. 30 indexed citations
6.
Erdogan, Fikret, et al.. (2000). Analysis of theNF1 gene by temperature gradient gel electrophoresis reveals a high incidence of mutations in exon 4b. Electrophoresis. 21(3). 541–544. 25 indexed citations
7.
Fahsold, Raimund, Sven Hoffmeyer, Claudia Mischung, et al.. (2000). Minor Lesion Mutational Spectrum of the Entire NF1 Gene Does Not Explain Its High Mutability but Points to a Functional Domain Upstream of the GAP-Related Domain. The American Journal of Human Genetics. 66(3). 790–818. 231 indexed citations
8.
Tinschert, Sigrid, et al.. (2000). Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. European Journal of Human Genetics. 8(6). 455–459. 120 indexed citations
9.
Stevenson, David A., Patricia Birch, Jan M. Friedman, et al.. (1999). Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. American Journal of Medical Genetics. 84(5). 413–419. 96 indexed citations
10.
Harder, Anja, Hartmut Peters, Sven Hoffmeyer, et al.. (1999). Two independent mutations in a family with neurofibromatosis type 1 (NF1). American Journal of Medical Genetics. 83(1). 6–12. 22 indexed citations
11.
Buske, Annegret, et al.. (1999). RecurrentNF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1). American Journal of Medical Genetics. 86(4). 328–330. 11 indexed citations
12.
Gottschalk, S., et al.. (1999). Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type 1: report of two cases. Neuroradiology. 41(3). 199–201. 44 indexed citations
13.
Harder, Anja, Hartmut Peters, Sven Hoffmeyer, et al.. (1999). Two independent mutations in a family with neurofibromatosis type 1 (NF1). American Journal of Medical Genetics. 83(1). 6–12. 2 indexed citations
14.
Harder, Anja, Peter N. Robinson, Andreas Gewies, et al.. (1998). Two novel mutations in exons 19a and 20 and a BsaI polymorphism in a newly characterized intron of the neurofibromatosis type 1 gene. Human Genetics. 102(3). 367–371. 5 indexed citations
15.
Böddrich, Annett, et al.. (1997). New evidence for a mutation hotspot in exon 37 of the NF1 gene. Human Mutation. 9(4). 374–377. 12 indexed citations
16.
Horn, Denise, et al.. (1996). Three novel mutations of the NF1 gene detected by temperature gradient gel electrophoresis of exons 5 and 8. Electrophoresis. 17(10). 1559–1563. 9 indexed citations
17.
Robinson, Peter N., et al.. (1996). Recurrent 2-bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis. Human Mutation. 7(1). 85–88. 12 indexed citations
18.
Robinson, Peter N., et al.. (1995). Two recurrent nonsense mutations and a 4 bp deletion in a quasi-symmetric element in exon 37 of the NF1 gene. Human Genetics. 96(1). 95–98. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026